GB9115740D0 - Medicaments - Google Patents

Medicaments

Info

Publication number
GB9115740D0
GB9115740D0 GB919115740A GB9115740A GB9115740D0 GB 9115740 D0 GB9115740 D0 GB 9115740D0 GB 919115740 A GB919115740 A GB 919115740A GB 9115740 A GB9115740 A GB 9115740A GB 9115740 D0 GB9115740 D0 GB 9115740D0
Authority
GB
United Kingdom
Prior art keywords
medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB919115740A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GB919115740A priority Critical patent/GB9115740D0/en
Publication of GB9115740D0 publication Critical patent/GB9115740D0/en
Priority to JP5502676A priority patent/JPH06509109A/ja
Priority to EP92915736A priority patent/EP0595910A1/fr
Priority to PCT/GB1992/001299 priority patent/WO1993001812A1/fr
Priority to AU23411/92A priority patent/AU2341192A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB919115740A 1991-07-20 1991-07-20 Medicaments Pending GB9115740D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GB919115740A GB9115740D0 (en) 1991-07-20 1991-07-20 Medicaments
JP5502676A JPH06509109A (ja) 1991-07-20 1992-07-16 選択的トリストミン　ｈ３受容体拮抗薬としてのｓ−（３−（４（５））−イミダゾリル）プロピル）イソチオウレア
EP92915736A EP0595910A1 (fr) 1991-07-20 1992-07-16 S-(3-(4(5)-imidazolyl)propyl)isothiouree utilisee comme antagoniste selectif de recepteur de tristomine h3
PCT/GB1992/001299 WO1993001812A1 (fr) 1991-07-20 1992-07-16 S-(3-(4(5)-imidazolyl)propyl)isothiouree utilisee comme antagoniste selectif de recepteur de tristomine h3
AU23411/92A AU2341192A (en) 1991-07-20 1992-07-16 S-(3-(4(5))-imidazolyl)propyl)isothiourea as selective trhistomine h3 receptor antagonist

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919115740A GB9115740D0 (en) 1991-07-20 1991-07-20 Medicaments

Publications (1)

Publication Number Publication Date
GB9115740D0 true GB9115740D0 (en) 1991-09-04

Family

ID=10698725

Family Applications (1)

Application Number Title Priority Date Filing Date
GB919115740A Pending GB9115740D0 (en) 1991-07-20 1991-07-20 Medicaments

Country Status (5)

Country Link
EP (1) EP0595910A1 (fr)
JP (1) JPH06509109A (fr)
AU (1) AU2341192A (fr)
GB (1) GB9115740D0 (fr)
WO (1) WO1993001812A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ276883A (en) * 1993-11-15 1998-08-26 Schering Corp 1h-imidazol-4-yl)alkyl]benzene derivatives
US6290986B1 (en) 1996-10-24 2001-09-18 Pharmaceutical Applications Associates, Llc Method and composition for transdermal administration of pharmacologic agents
US6479074B2 (en) 1996-10-24 2002-11-12 Pharmaceutical Applications Associates Llc Methods and transdermal compositions for pain relief
US6572880B2 (en) 1996-10-24 2003-06-03 Pharmaceutical Applications Associates Llc Methods and transdermal compositions for pain relief
US6407132B1 (en) 1997-07-25 2002-06-18 James Black Foundation Limited Substituted imidazole derivatives and their use as histamine H3 receptor ligands
US6133291A (en) * 1998-10-16 2000-10-17 Schering Corporation N-(imidazolylalkyl)substituted cyclic amines as histamine-H3 agonists or antagonists
US6211182B1 (en) 1999-03-08 2001-04-03 Schering Corporation Imidazole compounds substituted with a six or seven membered heterocyclic ring containing two nitrogen atoms
DE19940130A1 (de) 1999-08-24 2001-03-01 Probiodrug Ges Fuer Arzneim Neue Effektoren der Dipeptidyl Peptidase IV zur topischen Anwendung
JP2004509871A (ja) 2000-09-20 2004-04-02 シェーリング　コーポレイション 二重ヒスタミンｈ１およびｈ３のアゴニストまたはアンタゴニストとしての置換イミダゾール
AR032895A1 (es) 2000-09-20 2003-12-03 Schering Corp Imidazoles sustituidos como agonistas o antagonistas duales h1 y h3 de histamina
MXPA03002446A (es) 2000-09-20 2003-06-19 Schering Corp Imidazoles substituidos como agonistas o antagonistas duales h1 y h3 de histamina.
JP2004509869A (ja) 2000-09-20 2004-04-02 シェーリング　コーポレイション 二重ヒスタミンｈ１およびｈ３アゴニストまたはアンタゴニストとしての、置換されたイミダゾール
EP1408965A2 (fr) 2001-02-08 2004-04-21 Schering Corporation Utilisation d'antagonistes doubles h 3? et m 2? dans le traitement de troubles cognitifs
US20030130199A1 (en) 2001-06-27 2003-07-10 Von Hoersten Stephan Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agents
US6844316B2 (en) 2001-09-06 2005-01-18 Probiodrug Ag Inhibitors of dipeptidyl peptidase I
DE202004021723U1 (de) 2003-05-05 2010-07-15 Probiodrug Ag Medizinische Verwendung von Hemmern von Glutaminyl- und Glutamatcyclasen
ZA200508439B (en) 2003-05-05 2007-03-28 Probiodrug Ag Medical use of inhibitors of glutaminyl and glutamate cyclases
JP5707014B2 (ja) 2003-10-15 2015-04-22 プロビオドルグ エージー グルタミニル、及びグルタミン酸シクラーゼのエフェクターの使用
GB0324897D0 (en) * 2003-10-24 2003-11-26 Glaxo Group Ltd Composition
EP1713780B1 (fr) 2004-02-05 2012-01-18 Probiodrug AG Nouveaux inhibiteurs de la glutaminyl-cyclase
US20160022751A1 (en) * 2014-07-23 2016-01-28 Gangneung-Wonju National University Industry Academy Cooperation Group Novel composition for treating alzheimer's disease and improving cognitive function of alzheimer's patients

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3759944A (en) * 1970-10-14 1973-09-18 Smith Kline French Lab Isothioureas and their derivatives
FR2579596B1 (fr) * 1985-03-26 1987-11-20 Inst Nat Sante Rech Med (imidazolyl-4) piperidines, leur preparation et leur application en therapeutique
GB8916947D0 (en) * 1989-07-25 1989-09-13 Smith Kline French Lab Medicaments

Also Published As

Publication number Publication date
EP0595910A1 (fr) 1994-05-11
AU2341192A (en) 1993-02-23
WO1993001812A1 (fr) 1993-02-04
JPH06509109A (ja) 1994-10-13

Similar Documents

Publication Publication Date Title
OA09926A (en) Medicaments
ZA924658B (en) Medicaments
AP9100339A0 (en) Medicaments
GB9121204D0 (en) Medicament
GB9115740D0 (en) Medicaments
GB9121463D0 (en) Medicament
GB9122051D0 (en) Medicines
GB9104650D0 (en) Medicaments
GB9108348D0 (en) Medicaments
ZA927925B (en) Medicaments
GB9113383D0 (en) Medicaments
GB9110816D0 (en) Medicaments
ZA929617B (en) Medicaments
GB9117943D0 (en) Medicaments
GB9122472D0 (en) Medicaments
GB9126027D0 (en) Medicaments
GB9122475D0 (en) Medicaments
GB9100039D0 (en) Medicaments
GB9113787D0 (en) Medicaments
GB9105774D0 (en) Medicaments
GB9126405D0 (en) Medicaments
GB9126444D0 (en) Medicaments
GB9108349D0 (en) Medicaments
GB9109913D0 (en) Medicaments
GB9123597D0 (en) Medicaments